A medical marijuana dispensary in Acton announced it would reopen Wednesday, five weeks after being closed for security and labeling violations.
Mass Wellspring said it had “worked diligently” to update its policies to comply with the Cannabis Control Commission’s new regulations.
An unannounced inspection last month revealed violations such as unsecured marijuana in patient areas, a back door lacking a security alarm, and labels that didn’t state the products’ origins or whether they were lab-tested.
“Mass Wellspring plants and products were never a regulatory issue,” the dispensary said in a news release. “We have maintained the highest level of care for our plants during our retail closure.”
The commission ordered Mass Wellspring to stop producing, growing, processing, and selling marijuana on Feb. 8. The violations posed an “immediate or serious threat to the public health, safety, and welfare,” a spokeswoman for the commission said at the time.
Officials said then that the dispensary would have to show it fixed the problems before being allowed to reopen.
“There has been no recall on Massachusetts Wellspring products at this time but as part of the final order and agreement the [Registered Marijuana Dispensary] must submit any inventory that has been improperly stored for retesting,” a commission spokeswoman said Wednesday.
This was the latest action by state regulators, who are responsible for scrutinizing the new industry.
In January, the commission investigated MCR Labs in Framingham, after police reported the lab had improperly thrown out hundreds of vials of marijuana products in an unlocked dumpster. The lab promised to adhere to proper disposal rules.
In December, the Department of Public Health ordered Triple M to temporarily stop selling marijuana at its dispensaries in Mashpee and Plymouth over concerns about pesticides.
That came a few months after regulators found similar pesticide issues and ordered a temporary shutdown at Good Chemistry, which operates a production facility in Bellingham and a dispensary in Worcester.
Both Triple M and Good Chemistry said they had used only natural compounds such as pyrethrins, insect-repelling chemicals derived from chrysanthemum flowers.
Also in December, state health inspectors ordered a temporary closing of Apothca, which runs medical marijuana dispensaries in Arlington and Lynn, ordering the firm to stop selling certain products that are infused with CBD, a minimally psychoactive compound that can be derived from cannabis.
Frequently used to treat seizure and other disorders, CBD is available at health stores — but medical dispensaries can sell products only from the regulated supply chain. Apothca said the products were legal and lab-tested but agreed to stop selling them.Naomi Martin can be reached at firstname.lastname@example.org.